Developing SHP2-based combination therapy for KRAS-amplified cancer
Tianxia Li(Dana-Farber Cancer Institute), Adam J. Bass(Broad Institute)
Cited by 27
Related Papers
CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinoma
|Nature Communications|2017|78
Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse Gastric Cancer
|Clinical Cancer Research|2022|19